Concepts (71)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autoimmune Diseases | 6 | 2021 | 164 | 3.080 |
Why?
|
| Uveitis | 6 | 2021 | 23 | 2.900 |
Why?
|
| Receptors, Melanocortin | 4 | 2021 | 6 | 2.120 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2020 | 45 | 1.280 |
Why?
|
| Spinal Cord Diseases | 2 | 2025 | 36 | 1.110 |
Why?
|
| Cervical Vertebrae | 3 | 2025 | 119 | 1.090 |
Why?
|
| Spinal Cord Compression | 2 | 2025 | 25 | 1.000 |
Why?
|
| Spleen | 3 | 2020 | 112 | 0.960 |
Why?
|
| White Matter | 1 | 2025 | 94 | 0.900 |
Why?
|
| Receptor, Adenosine A2A | 2 | 2021 | 4 | 0.870 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2025 | 257 | 0.840 |
Why?
|
| Autoimmunity | 3 | 2021 | 156 | 0.800 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2025 | 825 | 0.700 |
Why?
|
| Uvea | 1 | 2020 | 2 | 0.680 |
Why?
|
| Retinitis | 1 | 2020 | 9 | 0.670 |
Why?
|
| Serpins | 1 | 2020 | 31 | 0.670 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2020 | 59 | 0.650 |
Why?
|
| Receptors, Immunologic | 1 | 2020 | 72 | 0.650 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2019 | 39 | 0.650 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 208 | 0.630 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 283 | 0.600 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2019 | 97 | 0.590 |
Why?
|
| Disease Progression | 1 | 2019 | 473 | 0.550 |
Why?
|
| Macrophages | 1 | 2019 | 296 | 0.520 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 1570 | 0.490 |
Why?
|
| MicroRNAs | 1 | 2019 | 295 | 0.480 |
Why?
|
| Obesity | 1 | 2019 | 668 | 0.420 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 1461 | 0.340 |
Why?
|
| Animals | 6 | 2021 | 10399 | 0.320 |
Why?
|
| Mice, Knockout | 3 | 2021 | 845 | 0.300 |
Why?
|
| Mice | 4 | 2021 | 4645 | 0.270 |
Why?
|
| Middle Aged | 3 | 2025 | 7164 | 0.200 |
Why?
|
| Humans | 6 | 2025 | 28121 | 0.190 |
Why?
|
| Spondylosis | 1 | 2021 | 14 | 0.180 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 96 | 0.180 |
Why?
|
| Spinal Diseases | 1 | 2021 | 43 | 0.180 |
Why?
|
| Adult | 2 | 2025 | 7757 | 0.170 |
Why?
|
| Machine Learning | 1 | 2021 | 85 | 0.170 |
Why?
|
| Decompression, Surgical | 1 | 2021 | 76 | 0.170 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 35 | 0.170 |
Why?
|
| Antigen-Presenting Cells | 1 | 2019 | 32 | 0.160 |
Why?
|
| Immunomodulation | 1 | 2019 | 20 | 0.160 |
Why?
|
| CD11 Antigens | 1 | 2019 | 3 | 0.160 |
Why?
|
| Freund's Adjuvant | 1 | 2019 | 8 | 0.160 |
Why?
|
| Th1 Cells | 1 | 2019 | 36 | 0.160 |
Why?
|
| Immunity | 1 | 2019 | 26 | 0.160 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 74 | 0.160 |
Why?
|
| Organ Specificity | 1 | 2019 | 82 | 0.160 |
Why?
|
| Interleukin-17 | 1 | 2019 | 52 | 0.160 |
Why?
|
| Interferon-gamma | 1 | 2019 | 107 | 0.150 |
Why?
|
| Male | 3 | 2025 | 13487 | 0.150 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 509 | 0.150 |
Why?
|
| Diet, High-Fat | 1 | 2019 | 136 | 0.150 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 165 | 0.150 |
Why?
|
| Autoantigens | 1 | 2019 | 212 | 0.150 |
Why?
|
| Female | 3 | 2025 | 15156 | 0.140 |
Why?
|
| Cells, Cultured | 1 | 2020 | 985 | 0.140 |
Why?
|
| Cytokines | 1 | 2019 | 445 | 0.140 |
Why?
|
| Biomarkers | 1 | 2019 | 755 | 0.130 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 633 | 0.120 |
Why?
|
| Aged | 1 | 2025 | 5416 | 0.120 |
Why?
|
| Signal Transduction | 1 | 2019 | 1433 | 0.100 |
Why?
|
| Neck Muscles | 1 | 2021 | 3 | 0.050 |
Why?
|
| Musculoskeletal System | 1 | 2021 | 6 | 0.050 |
Why?
|
| Paraspinal Muscles | 1 | 2021 | 10 | 0.050 |
Why?
|
| Neck | 1 | 2021 | 26 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 105 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2021 | 118 | 0.040 |
Why?
|
| Lumbar Vertebrae | 1 | 2021 | 124 | 0.040 |
Why?
|
| Algorithms | 1 | 2021 | 433 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2021 | 2380 | 0.030 |
Why?
|